| Title : Need for an Update for the Guideline for the Management of Mild Cognitive Impairment - Kim_2022_Dement.Neurocogn.Disord_21_107 |
| Author(s) : Kim M , Moon SY |
| Ref : Dement Neurocogn Disord , 21 :107 , 2022 |
| Abstract : |
| PubMedSearch : Kim_2022_Dement.Neurocogn.Disord_21_107 |
| PubMedID: 36407292 |
| Title : Need for an Update for the Guideline for the Management of Mild Cognitive Impairment - Kim_2022_Dement.Neurocogn.Disord_21_107 |
| Author(s) : Kim M , Moon SY |
| Ref : Dement Neurocogn Disord , 21 :107 , 2022 |
| Abstract : |
| PubMedSearch : Kim_2022_Dement.Neurocogn.Disord_21_107 |
| PubMedID: 36407292 |
| Title : Need for an Update for the Guideline for the Management of Mild Cognitive Impairment - Kim_2022_Dement.Neurocogn.Disord_21_107 |
| Author(s) : Kim M , Moon SY |
| Ref : Dement Neurocogn Disord , 21 :107 , 2022 |
| Abstract : |
| PubMedSearch : Kim_2022_Dement.Neurocogn.Disord_21_107 |
| PubMedID: 36407292 |
| Title : Effective, Facile, and Selective Hydrolysis of the Chemical Warfare Agent VX Using Zr6-Based Metal-Organic Frameworks - Moon_2015_Inorg.Chem_54_10829 |
| Author(s) : Moon SY , Wagner GW , Mondloch JE , Peterson GW , DeCoste JB , Hupp JT , Farha OK |
| Ref : Inorg Chem , 54 :10829 , 2015 |
| Abstract : |
| PubMedSearch : Moon_2015_Inorg.Chem_54_10829 |
| PubMedID: 26505999 |
| Title : Effective, Facile, and Selective Hydrolysis of the Chemical Warfare Agent VX Using Zr6-Based Metal-Organic Frameworks - Moon_2015_Inorg.Chem_54_10829 |
| Author(s) : Moon SY , Wagner GW , Mondloch JE , Peterson GW , DeCoste JB , Hupp JT , Farha OK |
| Ref : Inorg Chem , 54 :10829 , 2015 |
| Abstract : |
| PubMedSearch : Moon_2015_Inorg.Chem_54_10829 |
| PubMedID: 26505999 |
| Title : Effective, Facile, and Selective Hydrolysis of the Chemical Warfare Agent VX Using Zr6-Based Metal-Organic Frameworks - Moon_2015_Inorg.Chem_54_10829 |
| Author(s) : Moon SY , Wagner GW , Mondloch JE , Peterson GW , DeCoste JB , Hupp JT , Farha OK |
| Ref : Inorg Chem , 54 :10829 , 2015 |
| Abstract : |
| PubMedSearch : Moon_2015_Inorg.Chem_54_10829 |
| PubMedID: 26505999 |
| Title : Effect of Rivastigmine or Memantine Add-on Therapy Is Affected by Butyrylcholinesterase Genotype in Patients with Probable Alzheimer's Disease - Han_2014_Eur.Neurol_73_23 |
| Author(s) : Han HJ , Kwon JC , Kim JE , Kim SG , Park JM , Park KW , Park KC , Park KH , Moon SY , Seo SW , Choi SH , Cho SJ |
| Ref : Eur Neurol , 73 :23 , 2014 |
| Abstract : |
| PubMedSearch : Han_2014_Eur.Neurol_73_23 |
| PubMedID: 25376930 |
| Title : Effect of Rivastigmine or Memantine Add-on Therapy Is Affected by Butyrylcholinesterase Genotype in Patients with Probable Alzheimer's Disease - Han_2014_Eur.Neurol_73_23 |
| Author(s) : Han HJ , Kwon JC , Kim JE , Kim SG , Park JM , Park KW , Park KC , Park KH , Moon SY , Seo SW , Choi SH , Cho SJ |
| Ref : Eur Neurol , 73 :23 , 2014 |
| Abstract : |
| PubMedSearch : Han_2014_Eur.Neurol_73_23 |
| PubMedID: 25376930 |
| Title : Effect of Rivastigmine or Memantine Add-on Therapy Is Affected by Butyrylcholinesterase Genotype in Patients with Probable Alzheimer's Disease - Han_2014_Eur.Neurol_73_23 |
| Author(s) : Han HJ , Kwon JC , Kim JE , Kim SG , Park JM , Park KW , Park KC , Park KH , Moon SY , Seo SW , Choi SH , Cho SJ |
| Ref : Eur Neurol , 73 :23 , 2014 |
| Abstract : |
| PubMedSearch : Han_2014_Eur.Neurol_73_23 |
| PubMedID: 25376930 |